New breast cancer drug that slows tumour growth
UK scientists have engineered a new breast cancer treatment that can slow down the tumour growth by nine months, delaying the need for chemotherapy. It was formed by combining a new treatment called palbociclib with an established hormone drug called fulvestrant. In 67% of the cases, the drug either reduced the tumour size or controlled the disease for six months.